Brand Name
|
Active Ingredient(s)
|
Drug Manufacturer
|
Daklinza
|
Daclatasvir
|
Bristol-Myers Squibb
|
Epclusa
|
Sofosbuvir and velpatasvir
|
Gilead Sciences
|
Harvoni
|
Ledipasvir and sofosbuvir
|
Gilead Sciences
|
Olysio
|
Simeprevir
|
Janssen
|
Sovaldi
|
Sofosbuvir
|
Gilead Sciences
|
Technivie
|
Ombitasvir and paritaprevir and ritonavir
|
AbbVie
|
Viekira Pak
|
Dasabuvir and ombitasvir and paritaprevir and ritonavir
|
AbbVie
|
Viekira Pak XR
|
Dasabuvir and ombitasvir and paritaprevir and ritonavir
|
AbbVie
|
Zepatier
|
eEbasvir and grazoprevir
|
Merck Sharp Dohme
|
Source: FDA
|
Thursday, October 13, 2016
9項C肝炎藥 FDA提出警告(增加B肝炎復發風險): Daklinza/ Epclusa/ Harvoni/ Olysio/ Sovaldi/ Technivie/ Viekira Pak/ Viekira Pak XR/ Zepatier
醫療人工智慧: 百度醫療大腦 PK Google DeepMind和IBM Watson
百度今推醫療大腦 人工智慧結合醫療 2016年10月11日 19:15 賴昭男 新浪科技報導,百度今(11)日推出「百度醫療大腦」,
Artificial Intelligence Fights Breast Cancer – Google DeepMind and IBM Watson in Healthcare
By Shudeep Chandrasekhar - August 31, 2016315 Over the past few weeks I've written several articles on the good and bad of artificial intelligence. On the good side there are projects that make our lives easier; on the bad, there are things that could end our lives. But possibly the most useful of all artificial intelligence applications is what IBM Watson and Google DeepMind are doing in the area of oncology, or cancer treatment.
How Prevalent is Breast Cancer? According to the World Cancer Research Fund International, breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. There's no recent data on this, but it is known that "the highest incidence of breast cancer was in Northern America and Oceania; and the lowest incidence in Asia and Africa." One of the things IBM Watson helps with is to research everything – and I mean EVERYTHING – ever published on a single type of cancer, compare it with medical images and test results for a particular patient with breast cancer, and recommend the best course of treatment. It even suggest the best clinical trials that the patient can go on that has the highest probability of success. This capability saves doctors and medical technicians hours of research before they can recommend the best treatment for a patient.
Other Cancers and Diseases Google DeepMind, on the other hand, is focusing on head and neck cancers, which typically take hours of preparation before technicians can prepare a "map" of where radiotherapy can be applied. This prevents any damage to surrounding healthy tissue. Another are that DeepMind is working on is diagnosing eye diseases using retinal scan images. It works very similar to IBM Watson in that it will compare the patient's retinal scans with millions of anonymized images from other patients with all types of eye diseases to find the best match.
Implications for Healthcare When I interviewed IBM's Deborah DiSanzo a couple of months ago, she indicated that there was $800 BILLION being wasted in the healthcare segment. Much of this waste is in the form of labor-intensive tasks, unnecessary tests and so on. The purpose of IBM Watson Health is to not only help reduce this wastage, but also make it easier for doctors to go through billions of medical images and accurately diagnose a patient's condition. But Watson goes one step further and even recommends the best type of treatment, and that includes any current clinical trials being conducted by pharmaceutical companies. At the University of Texas MD Anderson Cancer Center, Assistant Professor of Leukemia Dr. Courtney DiNardo uses IBM's Watson cognitive system while consulting with patient Rich Ware, on October 18, 2013. Starting with the fight against Leukemia, IBM's Watson will help MD Anderson physicians develop, observe and fine tune cancer treatment plans, match patients with clinical trials and recognize adverse effects during ongoing care. At the University of Texas MD Anderson Cancer Center, Assistant Professor of Leukemia Dr. Courtney DiNardo uses IBM's Watson cognitive system while consulting with patient Rich Ware, on October 18, 2013. Starting with the fight against Leukemia, IBM's Watson will help MD Anderson physicians develop, observe and fine tune cancer treatment plans, match patients with clinical trials and recognize adverse effects during ongoing care. Cost and time savings aside, the introduction of artificial intelligence in the healthcare segment will contribute immensely to the accuracy of diagnosis and identifying the right treatment for a particular disease. Artificial intelligence is already permeating our daily lives in ways we don't even realize, but this is one of the applications that I feel will change the way the entire healthcare system works. More on that soon, so watch this space.
佰研 營收19個月來新低
生技哀嚎 岱宇、佰研重傷 2016-10-11 14:07聯合晚報 記者嚴雅芳/台北報導 生技股今日回檔力道強勁,掛牌新股岱宇(1598)
智擎 列注意股票 (借券賣出成交量…放大11倍..)
智擎、精測等7檔 列注意股票 2016年10月12日 智擎:近六個營業日(自當日之前一個營業日起)之借券賣出成交量
藉中國反貪腐政策! 合富 層峰計畫3.33%滲透率 強化中….
合富9月營收2.44億,月減5%,Q4審慎樂觀MoneyDJ
合度精密生技 開發 健檢技術 (大腸直腸癌篩檢)
合度生技CMx檢測平台 腸癌篩檢新福音 2016-07-26 19:20:36 經濟日報 蘇璽文合度精密生物科技深耕於精準癌症檢測技術,今(26)日宣
潤霈&北京雷德睦華 推廣 PRP傷口治療 (SFDA許可: SEPAX系統平台)
潤霈生技 開啟再生醫學交流新領域 2016-10-11 15:01:41 經濟日報 李憶伶 潤霈生技與北京雷德睦華公司,於大陸燒、創傷修復醫學大會上,
新竹馬偕五&峰鄉衛生所 共組 居家醫療團隊
五峰靈芝醫療團隊 到宅看診、送藥、安寧照護 2016-10-11[記者廖雪茹/新竹報導]健保署推動「
秀傳 手術3D顯微鏡 預2016Q4歐盟CE認證
秀傳跑得快 通吃微創手術軟硬商機 財訊雙週刊 第 513 期 作者:郭庭昱 微創手術從萌芽到普及,台灣醫界都在第一時間就參與,
最早嗅到商機 看好微創醫療潛力 瞄準亞洲市場「他算是老頑童,對新鮮的東西都很有興趣」,
架設兩大支柱 訓練中心與育成中心各有目標 台灣產業的強項是資通訊、光機電整合,
(亞大附醫 趙明哲) 肉毒桿菌 治療中風 (能申請健保)
肉毒桿菌不只用醫美 治療中風也有效果2016/10/11 17:47陳宏睿 / 報導 民眾熟悉肉毒桿菌在醫美技術的運用,讓皮膚有更緊緻的效果,但事
中州科大 (鄭朝旭) 檜木香氣金屬辦公用具: 金牌 (發明暨技術交易展)
中州科大 獲台北國際發明展佳績 2016年10月12日 04:10 陳仁義 文/陳仁義 日前於台北世貿盛大展出的「2016年台北國際發明暨技術交易展